Advanos Announces Board Approval of Q1 2026 Consolidated Financial Report

1. Date of Report to or Resolution by the Board of Directors: May 5, 2026 2. Date of Approval by the Audit Committee: May 5, 2026 3. Reporting Period of Financial Report or Annual Self-Audited Financial Information: From January 1, 2026 to March 31, 2026 4. Cumulative Operating Revenue from January 1 to the end of this period (in thousands of NTD): 3,030,612 5. Cumulative Operating Gross Profit (Loss) from January 1 to the end of this period (in thousands of NTD): 754,408 6. Cumulative Operating Income (Loss) from January 1 to the end of this period (in thousands of NTD): 168,760 7. Cumulative Pre-tax Net Profit (Loss) from January 1 to the end of this period (in thousands of NTD): 160,589 8. Cumulative Net Profit (Loss) for this period from January 1 to the end of this period (in thousands of NTD): 120,365 9. Cumulative Net Profit (Loss) Attributable to Owners of the Parent from January 1 to the end of this period (in thousands of NTD): 86,809 10. Cumulative Basic Earnings Per Share (Loss) from January 1 to the end of this period (in NTD): 0.76 11. Total Assets at Period End (in thousands of NTD): 13,261,955 12. Total Liabilities at Period End (in thousands of NTD): 7,705,318 13. Equity Attributable to Owners of the Parent at Period End (in thousands of NTD): 3,228,548 14. Other Matters to be Specified: None